Loading insider details...
Beta
Latest Form 4 (Jun 25, 2026): Exercise/Conversion of 4,712 RYTM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 25, 2026 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 4,712 | n/a |
| Jun 12, 2026 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 1,371 | n/a |
| May 22, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 671 | n/a |
| Feb 10, 2026 | Praxis Precision Medicines, Inc. (PRAX) | Grant/Award | 688 | n/a |
| Jan 7, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,279 | n/a |
| Jul 2, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 37,243 | $16.77M |
| Jun 26, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/Award | 7,037 | n/a |
| Jun 23, 2025 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Exercise/Conversion | 4,000 | n/a |
| May 15, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 37,622 | n/a |
| Feb 28, 2025 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 7,071 | $3.39M |